Key Highlights: Implications: Survey hands GSK potent ammo to ignite shingles vaccination drives targeting CKD/diabetes clinics where patient disruption peaks. Chronic disease n...
Key Highlights: Implications: StopBleed fills critical gap in India’s trauma response, handing emergency teams a game-changing tool that slashes preventable bleeding death...
Key Highlights: Implications: Lilly’s India manufacturing bet locks in low-cost production muscle, outflanking China-dependent rivals as Mounjaro mania drives capacit...
Key Highlights: Implications: PEPAIR smashes cost barriers to OPEP therapy, handing pulmonologists a game-changing tool that slots perfectly alongside Zydus inhalers and Deriphyllin....
Key Highlights: Implications: CANTAB’s India entry taps the $1B+ digital diagnostics market (25% CAGR), challenging manual screening while accelerating early dementia detection amid ...
Key Highlights: Implications: Dr. Reddy’s grabs monopoly control over Hepatitis E prevention, dominating public health tenders and private vaccination drives as awareness explo...
Key Highlights: Implications: PrecisionCHD taps India’s $1.5B+ cardiac diagnostics market (15% CAGR), challenging ECG/stress tests via molecular insights and Dr Lal’s netw...
Key Highlights: Implications: The CDSCO approval gives India access to a new category of portable, AI-enabled MRI, which can begin to address the structural gap between neuroimaging ...
Key Highlights: Implications: TRIA disrupts India’s heart valve market by eliminating lifelong blood thinners, handing cardiothoracic surgeons a patient-friendly alte...
